Neil Clark is the founder of Destiny Pharma. Destiny Pharma has raised $21M in total funding. Backed by finnCap, Sebela Pharmaceutical.
Neil Clark is the CEO of Destiny Pharma, a clinical-stage biotechnology company focused on developing novel medicines to prevent life-threatening infections. The company is committed to developing drugs to prevent and treat infections and has been doing so for 20 years. Destiny Pharma raised £10.4 million through an equity placing, and later up to £7.0 million in March 2022 to progress its lead clinical assets towards Phase 3 trials.
Full founder directory · Investor directory · Company funding database · Fundraising library